The 2016 revision to the World Health Organization classification of myelodysplastic syndromes
Authors:
Open Access
- 1 September 2017
- journal article
- Published by Walter de Gruyter GmbH in Journal of Translational Internal Medicine
- Vol. 5 (3) , 139-143
Abstract
Sciendo provides publishing services and solutions to academic and professional organizations and individual authors. We publish journals, books, conference proceedings and a variety of other publications.Keywords
This publication has 18 references indexed in Scilit:
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patientsBlood, 2014
- Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2014
- Clinical and genetic predictors of prognosis in myelodysplastic syndromesHaematologica, 2014
- p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)Haematologica, 2014
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromesLeukemia, 2013
- Revised International Prognostic Scoring System for Myelodysplastic SyndromesBlood, 2012
- Prognostic irrelevance of ring sideroblast percentage in World Health Organization–defined myelodysplastic syndromes without excess blastsBlood, 2012
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease ProgressionJournal of Clinical Oncology, 2011